ASH 2019 Highlights

Newton, MA US
January 11, 2020

Description

The care of patients with hematologic malignancies is evolving rapidly. This continuing medical education activity will discuss new developments in the diagnosis and treatment of hematologic malignancies, as presented at the 2019 Annual Meeting of the American Society of Hematology (ASH).

At this one-day course, faculty will share the latest updates in lymphoma, leukemia, multiple myeloma, coagulation disorders, and stem cell transplantation. Through case-based presentations and Q&A, attendees will gain a deeper understanding of emerging treatments available for blood cancers and blood disorders and learn how these new therapies can be integrated into daily practice.

Target Audience

This activity is directed toward hematologists, medical oncologists, internists, nurse practitioners, oncology nurses, and other interested healthcare providers.

Learning Objectives

At the conclusion of this course, attendees will be able to:

  1. Provide an overview and highlight the recent medical advances presented at the 2019 Annual Meeting of the American Society of Hematology, which will help physicians achieve better patient outcomes.
  2. Recognize appropriate management and treatment options for hematologic malignancies and utilize these approaches in routine clinical practice for stem cell transplantation, lymphoma, multiple myeloma, acute lymphocytic leukemia and chronic myelogenous leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, acute promyelocytic leukemia and myelodysplastic syndrome.
  3. Recognize new therapies and approaches in non-malignant hematology.

 

About the Center for Hematologic Oncology at Dana-Farber/Brigham and Women's Cancer Center

We offer advanced, specialized care for patients with all types of hematologic malignancies, including leukemia and similar bone marrow disorders, lymphoma, multiple myeloma, Waldenström’s macroglobulinemia, and other related blood disorders.

Dana-Farber/Brigham and Women’s Cancer Center is at the forefront of stem cell transplantation, performing more than 500 transplants each year. Our team of specialists are national leaders in basic and clinical research designed to bring cutting-edge, innovative therapies to patients with blood cancers. The program is committed to working closely with referring oncologists to jointly devise clinical strategies to improve the care of our patients.

Additional Information

Provided by: 

Dana-Farber/Brigham and Women's Cancer Center and Partners HealthCare System

 

 

Course summary
Available credit: 
  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 Participation
Course opens: 
10/07/2019
Course expires: 
02/11/2020
Event starts: 
01/11/2020 - 7:30am
Event ends: 
01/11/2020 - 2:15pm
Cost:
$75.00
Boston Marriott Newton Hotel
2345 Commonwealth Avenue
Newton, MA 02466
United States

Ann S. LaCasce, MD, MMSc - Course Director

Director, Dana-Farber/Partners CancerCare Hematology-Medical Oncology Fellowship Program,
Medical Oncologist, Adult Lymphoma Program,
Dana-Farber/Brigham and Women’s Cancer Center;
Associate Professor of Medicine, Harvard Medical School


Jean M. Connors, MD

Medical Director, Anticoagulation Management Service,
Dana-Farber/Brigham and Women’s Cancer Center;
Associate Professor of Medicine, Harvard Medical School


Matthew S. Davids, MD, MMSc

Associate Director, Center for Chronic Lymphocytic Leukemia,
Dana-Farber/Brigham and Women’s Cancer Center;
Assistant Professor of Medicine, Harvard Medical School


Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia,
Dana-Farber/Brigham and Women’s Cancer Center;
Professor of Medicine, Harvard Medical School


Eric D. Jacobsen, MD

Clinical Director, Adult Lymphoma Program,
Director, Histiocyte Disorders Center,
Dana-Farber/Brigham and Women’s Cancer Center;
Assistant Professor of Medicine, Harvard Medical School


Clifton C. Mo, MD

Director, Autologous Stem Cell Transplantation for Multiple Myeloma,
Dana-Farber/Brigham and Women’s Cancer Center


Rizwan Romee, MD

Director, Haploidentical Donor Transplantation Program,
Dana-Farber/Brigham and Women’s Cancer Center;
Associate Professor of Medicine, Harvard Medical School


Richard M. Stone, MD

Chief of Staff, Dana-Farber Cancer Institute;
Director, Translational Research, Adult Leukemia Program,
Dana-Farber/Brigham and Women’s Cancer Center;
Professor of Medicine, Harvard Medical School

Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Partners HealthCare System designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 


Nursing Credits

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 5.0 continuing education contact hours through the California Board of Registered Nursing. Approval Period: December 2017-December 2020.

LLS maintains responsibility for the program.  Upon completion of this program and submission of the activity evaluation, a certificate of completion will be provided to you within 30 days.

Available Credit

  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 Participation

Accreditation Period

Course opens: 
10/07/2019
Course expires: 
02/11/2020

Price

Cost:
$75.00
Please login or register to take this course.

Registration Fee: non-refundable, includes course materials, continental breakfast, lunch, and complimentary parking

  • $75.00 through December 30, 2019
  • $85.00 after December 30, 2019


For questions regarding registration, please contact the Partners Office of Continuing Professional Development at partnerscpd@partners.org.

For questions regarding the conference, please call 1-800-553-3787.

If you have any food allergies, or if you require accommodations such as an ASL interpreter, materials in an alternative format, or wheelchair access, please contact our course coordinator at kwooten@partners.org or call 1-800-553-3787 before the live event.